257 related articles for article (PubMed ID: 10726056)
1. Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.
Morrey JD; Korba BE; Sidwell RW
Antivir Ther; 1998; 3(Suppl 3):59-68. PubMed ID: 10726056
[TBL] [Abstract][Full Text] [Related]
2. Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy.
Li D; Xu DZ; Choi BC; Men K; Zhang JX; Lei XY; Yan YP
J Med Virol; 2005 Jun; 76(2):203-7. PubMed ID: 15834875
[TBL] [Abstract][Full Text] [Related]
3. [Study on efficacy and safety of lamivudine and interferon-alpha in treatment of hepatitis B virus transgenic mice with pregnancy].
Li D; Yan YP; Xu DZ; Men K; Zhang JX; Lei XY
Zhonghua Fu Chan Ke Za Zhi; 2005 May; 40(5):315-9. PubMed ID: 15938781
[TBL] [Abstract][Full Text] [Related]
4. The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents.
Ilan E; Burakova T; Dagan S; Nussbaum O; Lubin I; Eren R; Ben-Moshe O; Arazi J; Berr S; Neville L; Yuen L; Mansour TS; Gillard J; Eid A; Jurim O; Shouval D; Reisner Y; Galun E
Hepatology; 1999 Feb; 29(2):553-62. PubMed ID: 9918935
[TBL] [Abstract][Full Text] [Related]
5. [Establishment and identification of highly expressing and replicating hepatitis B virus genome transgenic mouse models].
Wu Jm; Lin JS; Chen BT; Zheng XM; Zhao HB; Liang KH
Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):338-40. PubMed ID: 12837210
[TBL] [Abstract][Full Text] [Related]
6. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
Marinos G; Naoumov NV; Williams R
Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365
[TBL] [Abstract][Full Text] [Related]
7. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
Petit MA; Buffello-Le Guillou D; Roche B; Dussaix E; Duclos-Vallée JC; Féray C; Samuel D
J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus transgenic mice for the model of anti-hepatitis B virus drug study.
Xiong Y; Jia Y; Wang H; Liu G; Ren H; Zhuo Z; Zhang D
Zhonghua Gan Zang Bing Za Zhi; 2001 Feb; 9(1):19-21. PubMed ID: 11242128
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees.
Eren R; Ilan E; Nussbaum O; Lubin I; Terkieltaub D; Arazi Y; Ben-Moshe O; Kitchinzky A; Berr S; Gopher J; Zauberman A; Galun E; Shouval D; Daudi N; Eid A; Jurim O; Magnius LO; Hammas B; Reisner Y; Dagan S
Hepatology; 2000 Sep; 32(3):588-96. PubMed ID: 10960454
[TBL] [Abstract][Full Text] [Related]
10. [Chronic hepatitis B. Recent advances in diagnosis and treatment].
Bernardi M; Biselli M; Gramenzi A
Recenti Prog Med; 2002; 93(7-8):397-402. PubMed ID: 12138683
[TBL] [Abstract][Full Text] [Related]
11. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
Lu H; Ma LX; Xu WS; Zhang HY; Yu LJ; Duan HY
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
Korba BE; Cote P; Hornbuckle W; Schinazi R; Gangemi JD; Tennant BC; Gerin JL
Antivir Ther; 2000 Jun; 5(2):95-104. PubMed ID: 10971862
[TBL] [Abstract][Full Text] [Related]
13. Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine.
Morrey JD; Bailey KW; Korba BE; Sidwell RW
Antiviral Res; 1999 Jun; 42(2):97-108. PubMed ID: 10389653
[TBL] [Abstract][Full Text] [Related]
14. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of a quantitative HBV-DNA PCR assay in lamivudine treated hepatitis B-infected patients].
Deal C; Ajana F; Canva V; Mouton Y; Yazdanpanah Y; Wattré P; Bocket L
Ann Biol Clin (Paris); 2002; 60(5):581-8. PubMed ID: 12368144
[TBL] [Abstract][Full Text] [Related]
16. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
[TBL] [Abstract][Full Text] [Related]
17. Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection.
Mutimer D; Dowling D; Cane P; Ratcliffe D; Tang H; O'Donnell K; Shaw J; Elias E; Pillay D
Antivir Ther; 2000 Dec; 5(4):273-7. PubMed ID: 11142622
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
19. Viral covalently closed circular DNA in a non-transgenic mouse model for chronic hepatitis B virus replication.
Takehara T; Suzuki T; Ohkawa K; Hosui A; Jinushi M; Miyagi T; Tatsumi T; Kanazawa Y; Hayashi N
J Hepatol; 2006 Feb; 44(2):267-74. PubMed ID: 16226822
[TBL] [Abstract][Full Text] [Related]
20. Stable transmission and expression of the hepatitis B virus total genome in hybrid transgenic mice until F10 generation.
Bagis H; Arat S; Mercan HO; Aktoprakligil D; Caner M; Turanli ET; Baysal K; Turgut G; Sekmen S; Cirakoglu B
J Exp Zool A Comp Exp Biol; 2006 May; 305(5):420-7. PubMed ID: 16489557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]